Pfizer Australia Pty Ltd—Dostinex, Cabaser and Methoblastin

PRA number

2015/14592

Published date

Product description

Prescription medications
Identifying features
Dostinex (cabergoline), Cabaser (cabergoline) & Methoblastin (methotrexate) - All Batches Dostinex (cabergoline) 0.5 mg tablet, bottles of 2 and 8 AUST R number: 52158 Cabaser (cabergoline) 1 mg tablet, bottles of 30 AUST R number: 57360 Cabaser (cabergoline) 2 mg tablet, bottles of 30 AUST R number: 57367 METHOBLASTIN (methotrexate) 2.5 mg tablets, bottles of 30 AUST R number: 15418 METHOBLASTIN (methotrexate) 10 mg tablets, bottles of 15 & 50 AUST R number: 15417

Other identifying numbers

Dostinex (cabergoline), Cabaser (cabergoline) & Methoblastin (methotrexate) - All Batches

Dostinex (cabergoline) 0.5 mg tablet, bottles of 2 and 8
AUST R number: 52158

Cabaser (cabergoline) 1 mg tablet, bottles of 30
AUST R number: 57360

Cabaser (cabergoline) 2 mg tablet, bottles of 30
AUST R number: 57367

METHOBLASTIN (methotrexate) 2.5 mg tablets, bottles of 30
AUST R number: 15418

METHOBLASTIN (methotrexate) 10 mg tablets, bottles of 15 & 50
AUST R number: 15417

Reasons the product is recalled

The products have been supplied in containers without child-resistant closures. Please note that there is no concern regarding the quality or safety of this medicine other than the absence of child resistant packaging.

The hazards to consumers

If children gain access to the products there is the potential for inadvertent poisoning.

What consumers should do

Consumers are asked to return any affected product to their Pharmacy to have either the cap or the container replaced with new child resistant closures.

Supplier

Pfizer Australia Pty Ltd

Traders who sold this product

Various Pharmacies nationwide

Where the product was sold

Nationally

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category

Pharmacy